MedPath

Effect of Psyllium seed on the gastric reflux in patients with constipatio

Phase 3
Conditions
Gastro-esophageal reflux disease.
Gastro-esophageal reflux disease with esophagitis
Registration Number
IRCT2015040315122N2
Lead Sponsor
Vice chancellor for research, Mashad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
132
Inclusion Criteria

Symptomatic patients with minimum three years history of gastroesophageal reflux disease and functional constipation whose esophagitis in upper endoscopy will be confirmed.
Exclusion criteria: History of or current gastrointestinal cancer; Hiatal hernia; Irritable bowel syndrome; Endocrine diseases (e.g., hypothyroidism); Drug-induced constipation; Psychological disorders; Cardiovascular diseases; Liver diseases; Renal diseases; Opiums abuse

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment reflux disease remission with constipation improvement. Timepoint: First day, 7th day, 14th day, 21th day, 28th day, 35th day,42th day, 49th day and 56th day after intervention. Method of measurement: History of heart burn and regurgitation(clinical symptoms of GERD) was taken. Then the visual scale was used for evaluation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath